Parathyroid surgery may boost mobility in seniors

NCT ID NCT07103876

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 37 times

Summary

This study looks at whether removing the parathyroid gland can improve physical function and mobility in adults aged 60 and older with primary hyperparathyroidism. Researchers will track changes in walking, strength, and daily activity before and after surgery, and analyze blood samples for clues. The goal is to gather evidence that could guide future treatments and potentially expand the use of this surgery for older patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY HYPERPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical and Translational Research Building

    RECRUITING

    Gainesville, Florida, 32610, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

parathyroidectomy (surgical removal of the parathyroid gland)

What this could lead to

If successful, this could show that parathyroid surgery improves mobility and quality of life in older adults, potentially expanding who might benefit from the procedure.

What could go wrong

This is an observational study, not a controlled trial, so it cannot prove cause and effect. It is also small (80 people) and early-stage, so results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

hyperparathyroidism Motor Activity parathyroid gland disorder primary hyperparathyroidism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.